Agilent Technologies, Inc. which can be found using ticker (A) have now 16 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between $163.00 and $105.00 and has a mean target at $135.75. Now with the previous closing price of $110.54 and the analysts are correct then there would likely be a percentage uptick in value of 22.8%. It’s also worth noting that there is a 50 day moving average of $111.09 and the 200 moving average now moves to $126.20. The company has a market cap of 32.01B. The stock price is currently at: $109.39 USD
The potential market cap would be $39,305,474,015 based on the market consensus.
The company has a dividend yield of 2.35%. Other points of data to note are a P/E ratio of 28.64, revenue per share of $23.69 and a 8.79% return on assets.
Agilent Technologies, Inc. is engaged in providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets business offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics businesses are comprised of six areas of activity, providing active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software, and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. Its product categories include liquid chromatography systems and components and liquid chromatography mass spectrometry systems.
